Mohamed Kandeel El-Ashrey

13PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsMolecular targetsBiologically active moleculesData visualisation and computational (incl. parametric and generative) design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 14, 2026
Design, synthesis, anticancer activity and molecular modeling of new pyrazoline derivatives as telomerase inhibitors.

|Mar 09, 2026
Exploring Pyrazolo[3,4-b]Pyridine and Spiro-Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling Insights.

Ahmed K B A W Farouk, Aya A A Al-Tanany, Mohamed R Elnagar

|Oct 03, 2025
Design, synthesis, and in silico studies of new benzofuran-pyrazole hybrids as multi-kinase inhibitors with potential antiproliferative activity.

Somaia S Abd El-Karim, Yasmin M Syam, Reham M Abdelkader

|Jun 27, 2025
New Nitrogen-, Oxygen-, and Sulfur-Containing Heterocyclic Compounds as Anti-Colon Cancer Agents: Synthesis, Multitargeted Evaluations, Molecular Docking Simulations and ADMET Predictions.

Nahed Nasser Eid El-Sayed, Najeh Krayem, Hamed Ahmed Derbala

|Jan 08, 2025
New Benzofuran-Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies.

Somaia S Abd El-Karim, Manal M Anwar, Yasmin M Syam

|Sep 04, 2024
New 6-nitro-4-substituted quinazoline derivatives targeting epidermal growth factor receptor: design, synthesis and in vitro anticancer studies.

Ayman B Farag, Aya H Othman, Mohamed K El-Ashrey

Pageof 3

Frequent Collaborators

2 joint publications

Nahed Nasser Eid El-Sayed

2 joint publications

Abir Ben Bacha

2 joint publications

Zainab M Almarhoon

2 joint publications

Somaia S Abd El-Karim